03/07
Headlines

Diversified Tech

FB Nasdaq FB Facebook

Unusual Volume Diversified Electronics: China BAK Battery (NASDAQ:CBAK), New Energy Systems (OTCMKTS:NEWN), Maxwell Technologies (NASDAQ:MXWL), Wells-Gardner (NYSEMKT:WGA)

Jason Knox02 mins

TheStreet rate CHINA BAK BATTERY INC (CBAK) a SELL. This is driven by a few notable weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results. China BAK Battery Inc. (NASDAQ:CBAK) stock performance was 22.85% in last session and finished the…

Read More

CarPlay: Another Innovation By Apple, Tesla Motors (NASDAQ:TSLA) & Apple Inc. (NASDAQ:AAPL) Are Worth Compatible For Partnership

Mark DeFrance02 mins

Apple Inc. (NASDAQ:AAPL)’s next innovation is coming this year in the form of CarPlay for car infotainment systems. Simply, it is an iOS in the Car iPhone incorporation system. The system works with iOS 7 and because of their Lightning connectivity, only iPhone 5 and above models of phone is compatible up to now. Just…

Read More

After-Hours Earnings Highlights: Mentor Graphics (NASDAQ:MENT), (NASDAQ:FSTR), (NASDAQ:CHUY), (NASDAQ:MNST)

Ryan Holtz03 mins

Mentor Graphics (NASDAQ:MENT) is steady after hours Thursday after it edges out the Street view with Q4 earnings and provides mixed guidance. The company reports non-GAAP income of $107 million or $0.92 per share compared to $67 million or $0.58 per share a year earlier. The company reports Q4 revenues of $401 million, up from…

Read More

Earnings Breakout: Inventure Foods (NASDAQ:SNAK), Vitacost.com (NASDAQ:VITC), Workday (NYSE:WDAY)

Mark Doerr02 mins

Inventure Foods (NASDAQ:SNAK) rose to record highs Thursday after the company reported better-than-expected financial results for Q4. Shares are up 8.84% at $13.79 late in the session, and earlier reached $14 – an all time high. The marketer and manufacturer of specialty snack food brands reported Q4 earnings of $0.14 per share, ex one-time items,…

Read More

Midday Gainers: Intermune Doubles; Tekmira Advances to Record High; Diamond Rock Hits 6-Year High

Jayne Crisman03 mins

InterMune (NASDAQ:ITMN) more than doubled Tuesday to its highest value since May 2011 after saying data from a phase 3 trial showed its Pirfenidone drug significantly reduced the progression of idiopathic pulmonary fibrosis. Near midday, ITMN had jumped 126.6% at $31.63 per share in recent trading. Earlier it hit $37.22. Also, significant treatment effects were…

Read More